1997
DOI: 10.1159/000276903
|View full text |Cite
|
Sign up to set email alerts
|

One-Week Use of Oxymetazoline Nasal Spray in Patients with Rhinitis medicamentosa 1 Year after Treatment

Abstract: The aim of the present study was to investigate whether patients with rhinitis medicamentosa who stopped using the topical vasoconstrictors may use these drugs again more than 1 year later. Eight patients received oxymetazoline nasal spray containing benzalkonium chloride 3 times daily for 7 days, 13–19 months after they had stopped using nasal decongestant sprays containing benzalkonium chloride. Before starting the course of treatment and after its conclusion, recordings of the mucosal surface positions were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 7 publications
0
6
0
1
Order By: Relevance
“…The reports addressing this recommendation are divided. Graf and colleagues, [15][16][17][18][19][20][21][22] in a series of articles, showed evidence of rebound and also suggested a role for the preservative benzalkonium chloride. In contrast, several studies have shown lack of rhinitis medicamentosa when oxymetazoline or xylometazoline was used for up to 8 weeks.…”
Section: Discussionmentioning
confidence: 99%
“…The reports addressing this recommendation are divided. Graf and colleagues, [15][16][17][18][19][20][21][22] in a series of articles, showed evidence of rebound and also suggested a role for the preservative benzalkonium chloride. In contrast, several studies have shown lack of rhinitis medicamentosa when oxymetazoline or xylometazoline was used for up to 8 weeks.…”
Section: Discussionmentioning
confidence: 99%
“…19,20 The concept of rebound congestion remains controversial. Although several studies found that rebound congestion developed after 3 to 10 days of topical decongestant use, [21][22][23][24][25] a similar number of studies also showed a lack of any rebound congestion with up to 8 weeks of use. [26][27][28] Such contradictory evidence raises doubts about the real existence of this effect.…”
Section: Discussionmentioning
confidence: 99%
“…• ▶ Tab. 3 zeigt ein Therapieschema zum Vorgehen bei kompliziertem Privinismus modifiziert nach [77,81,82].…”
Section: Rhinitis Medicamentosaunclassified